Doxycycline Fails To Prevent Growth of Aortic Aneurysms: Study
A new study warns that the antibiotic doxycycline appears to have no effect on reducing the size of aortic aneurysms.
A new study warns that the antibiotic doxycycline appears to have no effect on reducing the size of aortic aneurysms.
The FDA has expanded warnings about leaks linked to endovascular grafts to multiple devices used to treat abdominal aortic aneurysms.
Levaquin, Cipro and Avelox may increase the risk of heart valve regurgitations, which could lead to heart failure, according to the findings of a new study.
The FDA is warning that Levaquin, Cipro, Avelox and similar drugs are linked to an increased risk of aortic dissection.
A new study adds to the body of evidence linking antibiotics like Avelox, Cipro and Levaquin to an increased risk of aortic aneurysm and aortic dissection.
The findings of a new study indicate that Cipro side effects could increase the risk of aortic aneurysm, aortic dissection and death in those already at increased risk.
Production on the antibiotic Levaquin was discontinued in December ahead of new label warnings and a laundry list of recent side effect concerns.
The FDA warns that antibiotics like Levaquin, Cipro and Avelox can cause extremely low blood sugar, resulting in coma, and psychiatric side effects, and is requiring new label warnings.
The design of devices use to treat aortic aneurysms may result in an increased risk of rupture, the FDA warns.
Swedish researchers say the risk of misdiagnosis may make abdominal aortic aneurysm screening more harmful than beneficial.